Cancer Theranostics -

Cancer Theranostics (eBook)

eBook Download: PDF | EPUB
2014 | 1. Auflage
544 Seiten
Elsevier Science (Verlag)
978-0-12-407884-0 (ISBN)
Systemvoraussetzungen
Systemvoraussetzungen
155,00 inkl. MwSt
  • Download sofort lieferbar
  • Zahlungsarten anzeigen
Aiding researchers seeking to eliminate multi-step procedures, reduce delays in treatment and ease patient care, Cancer Theranostics reviews, assesses, and makes pertinent clinical recommendations on the integration of comprehensive in vitro diagnostics, in vivo molecular imaging, and individualized treatments towards the personalization of cancer treatment. Cancer Theranostics describes the identification of novel biomarkers to advance molecular diagnostics of cancer. The book encompasses new molecular imaging probes and techniques for early detection of cancer, and describes molecular imaging-guided cancer therapy. Discussion also includes nanoplatforms incorporating both cancer imaging and therapeutic components, as well as clinical translation and future perspectives. - Supports elimination of multi-step approaches and reduces delays in treatments through combinatorial diagnosis and therapy - Fully assesses cancer theranostics across the emergent field, with discussion of biomarkers, molecular imaging, imaging guided therapy, nanotechnology, and personalized medicine - Content bridges laboratory, clinic, and biotechnology industries to advance biomedical science and improve patient management
Aiding researchers seeking to eliminate multi-step procedures, reduce delays in treatment and ease patient care, Cancer Theranostics reviews, assesses, and makes pertinent clinical recommendations on the integration of comprehensive in vitro diagnostics, in vivo molecular imaging, and individualized treatments towards the personalization of cancer treatment. Cancer Theranostics describes the identification of novel biomarkers to advance molecular diagnostics of cancer. The book encompasses new molecular imaging probes and techniques for early detection of cancer, and describes molecular imaging-guided cancer therapy. Discussion also includes nanoplatforms incorporating both cancer imaging and therapeutic components, as well as clinical translation and future perspectives. - Supports elimination of multi-step approaches and reduces delays in treatments through combinatorial diagnosis and therapy- Fully assesses cancer theranostics across the emergent field, with discussion of biomarkers, molecular imaging, imaging guided therapy, nanotechnology, and personalized medicine- Content bridges laboratory, clinic, and biotechnology industries to advance biomedical science and improve patient management

List of Contributors


Archie A. Alexander,     James K. Elrod Department of Health Administration, Louisiana State University, Shreveport, Louisiana, U.S.A.

Miguel Valdivia y Alvarado,     Houston Methodist Research Institute, Weill Cornell Medical College, Texas, U.S.A.

Emma L.B. Anquillare,     Laboratory of Nanomedicine and Biomaterials, Department of Anesthesiology, Brigham and Women’s Hospital, Harvard Medical School, Boston, U.S.A.

Tobias Bäuerle

Department of Medical Physics in Radiology, German Cancer Research Center, Heidelberg, Germany

University Hospital Erlangen, Institute of Radiology, Maximiliansplatz 1, 91054 Erlangen, Germany

Weibo Cai

Department of Radiology, University of Wisconsin–Madison, Madison, Wisconsin, U.S.A

Department of Medical Physics, University of Wisconsin–Madison, Madison, Wisconsin, U.S.A

University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, U.S.A.

Warren C.W. Chan

Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, Canada

Donnelly Centre for Cellular and Biomedical Research, Department of Chemical Engineering, Department of Chemistry, Department of Materials Science and Engineering, University of Toronto, Toronto, Canada

Tou Pin Chang,     The Hamlyn Centre for Robotic Surgery, Imperial College, London, U.K.

Chin-Tu Chen,     Department of Radiology, University of Chicago, Chicago, Illinois, U.S.A.

Feng Chen

Theragnostic Laboratory, Department of Imaging and Pathology, University Hospital, University of Leuven, Leuven, Belgium

Department of Radiology, First Affiliated Hospital, Zhejiang University Hangzhou, Zhejiang, China

Jingyi Chen,     Department of Chemistry and Biochemistry, University of Arkansas, Fayetteville, Arkansas, U.S.A.

Nai-Tzu Chen,     Division of Medical Engineering Research, National Health Research Institutes, Zhunan Town, Miaoli County, Taiwan

Xiaoyuan Chen,     Laboratory of Molecular Imaging and Nanomedicine, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, Maryland, U.S.A.

Yun-Sheng Chen

Department of Biomedical Engineering, University of Texas at Austin, Austin, Texas, U.S.A

Department of Electrical and Computer Engineering, University of Texas at Austin, Austin, Texas, U.S.A.

Shih-Hsun Cheng,     Division of Medical Engineering Research, National Health Research Institutes, Zhunan Town, Miaoli County, Taiwan

Gi Hyun Choi,     Department of Maxillofacial Biomedical Engineering & Institute of Oral Biology, School of Dentistry, Kyung Hee University, Seoul, Republic of Korea

Mary K. Clancy,     Office of Research Protection, Methodist Hospital Research Institute, Houston, Texas, U.S.A.

Stanislav Y. Emelianov

Department of Biomedical Engineering, University of Texas at Austin, Austin, Texas, U.S.A

Department of Electrical and Computer Engineering, University of Texas at Austin, Austin, Texas, U.S.A.

Omid C. Farokhzad,     Laboratory of Nanomedicine and Biomaterials, Department of Anesthesiology, Brigham and Women’s Hospital, Harvard Medical School, Boston, U.S.A.

Liang Gao,     Chroma Technology Corporation, Bellows Falls, Vermont, U.S.A.

Tiancheng He,     Houston Methodist Research Institute, Weill Cornell Medical College, Texas, U.S.A.

Dong Nyoung Heo,     Department of Maxillofacial Biomedical Engineering & Institute of Oral Biology, School of Dentistry, Kyung Hee University, Seoul, Republic of Korea

Marshall E. Hicks,     University of Texas M.D. Anderson Cancer Center, Houston, Texas, U.S.A.

Don N. Ho,     Laboratory of Molecular Imaging and Nanomedicine, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, Maryland, U.S.A.

Kurt B. Hodges

Department of Basic Medical Sciences and Center for Cancer Research, Purdue University, West Lafayette, Indiana, U.S.A

Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana, U.S.A.

Shao-Ling Huang,     Division of Cardiology, Department of Internal Medicine, University of Texas at Houston Medical School, and Center for Clinical and Translational Sciences, University of Texas Health Science Center at Houston, Houston, Texas, U.S.A.

Elizabeth Huynh

Ontario Cancer Institute and Techna Institute, UHN, Toronto, Canada

Department of Medical Biophysics, University of Toronto, Toronto, Canada

Hossein Jadvar,     Keck School of Medicine of USC, University of Southern California, Los Angeles, California, U.S.A.

Guangxu Jin,     Department of Systems Medicine and Bioengineering, The Methodist Hospital Research Institute, Weill Cornell Medical College, Houston, Texas, U.S.A.

Fabrice Jotterand,     Institute of Biomedical Ethics, University of Basel, Switzerland

Dorde Komljenovic,     Department of Medical Physics in Radiology, German Cancer Research Center, Heidelberg, Germany

Il Keun Kwon,     Department of Maxillofacial Biomedical Engineering & Institute of Oral Biology, School of Dentistry, Kyung Hee University, Seoul, Republic of Korea

Sang Cheon Lee,     Department of Maxillofacial Biomedical Engineering & Institute of Oral Biology, School of Dentistry, Kyung Hee University, Seoul, Republic of Korea

Sophie A. Lelièvre,     Department of Basic Medical Sciences and Center for Cancer Research, Purdue University, West Lafayette, Indiana, U.S.A.

Fuhai Li,     Department of Systems Medicine and Bioengineering, Houston Methodist Hospital Research Institute, Weill Cornell Medical College, Houston, Texas, U.S.A.

Gang Liu

State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics & Center for Molecular Imaging and Translational Medicine, School of Public Health, Xiamen University, Xiamen, China

Sichuan Key Laboratory of Medical Imaging, North Sichuan Medical College, Nanchong, China

Tracy W. Liu

Ontario Cancer Institute and Techna Institute, UHN, Toronto, Canada

Department of Medical Biophysics, University of Toronto, Toronto, Canada

Leu-Wei Lo,     Division of Medical Engineering Research, National Health Research Institutes, Zhunan Town, Miaoli County, Taiwan

Kongkuo Lu,     Philips Research North America, New York, U.S.A.

Thomas D. MacDonald

Department of Pharmaceutical Sciences, University of Toronto, Toronto, Canada

Ontario Cancer Institute and Techna Institute, UHN, Toronto, Canada

James J. Mancuso,     Department of Systems Medicine and Bioengineering, Houston Methodist Hospital Research Institute, Weill Cornell Medical College, Houston, Texas, U.S.A.

David D. McPherson,     Division of Cardiology, Department of Internal Medicine, University of Texas at Houston Medical School, and Center for Clinical and Translational Sciences, University of Texas Health Science Center at Houston, Houston, Texas, U.S.A.

Kung Hyun Min,     Department of Life and Nanopharmaceutical Science, Kyung Hee University, Seoul, Republic of Korea

Tapas R. Nayak,     Department of Radiology, University of Wisconsin–Madison, Madison, Wisconsin, U.S.A.

Yicheng Ni,     Theragnostic Laboratory, Department of Imaging and Pathology, University Hospital, KU Leuven, Leuven, Belgium

Kinam Park,     Department of Maxillofacial Biomedical Engineering & Institute of Oral Biology, School of Dentistry, Kyung Hee University, Seoul, Republic of Korea

Ramasamy...

Erscheint lt. Verlag 20.3.2014
Sprache englisch
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Onkologie
Naturwissenschaften Biologie Genetik / Molekularbiologie
ISBN-10 0-12-407884-2 / 0124078842
ISBN-13 978-0-12-407884-0 / 9780124078840
Haben Sie eine Frage zum Produkt?
PDFPDF (Adobe DRM)
Größe: 91,7 MB

Kopierschutz: Adobe-DRM
Adobe-DRM ist ein Kopierschutz, der das eBook vor Mißbrauch schützen soll. Dabei wird das eBook bereits beim Download auf Ihre persönliche Adobe-ID autorisiert. Lesen können Sie das eBook dann nur auf den Geräten, welche ebenfalls auf Ihre Adobe-ID registriert sind.
Details zum Adobe-DRM

Dateiformat: PDF (Portable Document Format)
Mit einem festen Seiten­layout eignet sich die PDF besonders für Fach­bücher mit Spalten, Tabellen und Abbild­ungen. Eine PDF kann auf fast allen Geräten ange­zeigt werden, ist aber für kleine Displays (Smart­phone, eReader) nur einge­schränkt geeignet.

Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen eine Adobe-ID und die Software Adobe Digital Editions (kostenlos). Von der Benutzung der OverDrive Media Console raten wir Ihnen ab. Erfahrungsgemäß treten hier gehäuft Probleme mit dem Adobe DRM auf.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen eine Adobe-ID sowie eine kostenlose App.
Geräteliste und zusätzliche Hinweise

Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.

EPUBEPUB (Adobe DRM)
Größe: 14,4 MB

Kopierschutz: Adobe-DRM
Adobe-DRM ist ein Kopierschutz, der das eBook vor Mißbrauch schützen soll. Dabei wird das eBook bereits beim Download auf Ihre persönliche Adobe-ID autorisiert. Lesen können Sie das eBook dann nur auf den Geräten, welche ebenfalls auf Ihre Adobe-ID registriert sind.
Details zum Adobe-DRM

Dateiformat: EPUB (Electronic Publication)
EPUB ist ein offener Standard für eBooks und eignet sich besonders zur Darstellung von Belle­tristik und Sach­büchern. Der Fließ­text wird dynamisch an die Display- und Schrift­größe ange­passt. Auch für mobile Lese­geräte ist EPUB daher gut geeignet.

Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen eine Adobe-ID und die Software Adobe Digital Editions (kostenlos). Von der Benutzung der OverDrive Media Console raten wir Ihnen ab. Erfahrungsgemäß treten hier gehäuft Probleme mit dem Adobe DRM auf.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen eine Adobe-ID sowie eine kostenlose App.
Geräteliste und zusätzliche Hinweise

Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.

Mehr entdecken
aus dem Bereich
Entstehung, Progression und Therapie von Krebs

von Christoph Wagener; Oliver Müller

eBook Download (2022)
Thieme (Verlag)
199,99
Entstehung, Progression und Therapie von Krebs

von Christoph Wagener; Oliver Müller

eBook Download (2022)
Thieme (Verlag)
199,99
Handbuch für die Pflegepraxis

von Thomas Kroner; Anita Margulies; Sacha Rothschild …

eBook Download (2023)
Springer Berlin Heidelberg (Verlag)
29,99